Further GCLP Chemoproteomics contract secured

Summary by AI BETAClose X

Proteome Sciences PLC has secured a significant clinical contract for its GCLP-compliant chemoproteomics platform, its third contract related to the same protein for ongoing global phase 1 and phase 2 trials. The work, to be conducted in Frankfurt, Germany, is expected to commence with sample shipments later this year and the majority of the project completed in 2027. This contract underscores the demand from major biopharma clients for precise mass spectrometry-based protein assays to demonstrate drug effectiveness in clinical trials.

Disclaimer*

UK 100

Latest directors dealings